Recombinant interferon therapy in Indian children with HBV related chronic liver disease

Indian Pediatrics

Volumn 39, Issue 5, 2002, Pages 462-467

  Guptan, R C ^a   Thakur, V ^a   Malhotra, V ^a   Sarin, S K ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERFERON;

ABDOMINAL PAIN; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEVER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MALE; MORBIDITY; MORTALITY; RASH; RISK FACTOR; SCHOOL CHILD; SEIZURE; TREATMENT PLANNING;

ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INDIA; INFANT; INTERFERON TYPE I, RECOMBINANT; MALE; TREATMENT OUTCOME;

EID: 0036099225     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol 1987; 21: 137-145.
2. Fujisawa T, Komatsu H, Inui A, Sago T, Miyagawa Y, Fujitsuka S, et al. Long-term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood. J Pediatr Gastrenterol Nutr 2000; 30: 201-206.
3. Conjeevaram HS, DiBisceglie AM. Management of chronic viral hepatitis in children. J Pediatr Gastroenterol Nutr 1995; 4: 365-375.
4. Wong D, Cheung AM, O'Rourke KO, Naylor CD, Detsky AS, Heathcote J. Effect of alpha interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B: A metaanalysis. Ann Intern Med 1993; 119: 312-323.
5. Riz-Moreno, Jimenez J, Porres JS, Bartolome J, Moreno A, Carreno V. A controlled trial of recombinant interferon alpha in Caucasian children with chronic hepatitis B. Digestion 1990; 45: 26-33.
6. Torne D, Tambini R. Interferon alpha therapy for chronic hepatitis B in children: A metaanalysis. Clin Infect Dis 1996; 1: 131-137.
7. Bruguera M, Amat L, Garcia O, Lambruschini N, Carnicer J, Bergada A, et al. Treatment of chronic hepatitis B in children with recombinant alfa-interferon. Different response according to age at infection. J Clin Gastroenterol 1993; 17: 296-299.
8. Lok AS, Wu PC, Lai CL, Lau JY, Leung Ek, Wong LS, et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102: 2091-2097.
9. Knodell RG, Ishak KA. Black WL. Formulation of a numercial scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
10. Banerjee K, Sharma G, Upadhyay S, Anand SS, Raju GS, Khandekar P, et al. Detection of hepatitis B virus in blood samples negative for surface antigen by DNA probe hybridization assay. J Biol Sci 1989; 14: 279-287.
11. Sarin SK, Guptan RC, Thakur V, Malhotra S, Malhotra V, Banerjee K et al. Efficacy of low dose alpha interferon therapy in HBV related chronic liver disease in Asian Indians. A randomized controlled trial. J Hepatol 1996; 24: 391-396.
12. Lok AS, Lai CL. A longitudinal follow up of asymptomatic hepatitis B surface antigen positive Chinese children. Hepatology 1988; 8: 1130-1133.
13. Lai CL, Lok AS, Lin JH, Wu PC, Yeoh Ek, Yeung CY. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg - carrier children. Lancet 1987; 17: 2: 877-880.
14. Sokal EM, Conjeevaram HS, Roberts EA, Alvarej F, Fem Em, Goynes P, et al. Interferon alfa therapy for chronic hepatitis B in children. A multinational randomized controlled trial. Gastroenterology 1998; 114: 988-995.
15. Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to alfa-interferon therapy? A statistical analysis of predictive factors. Hepatology 1989; 10: 761-763.